You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Non-Marine-Based Fishmeal and Fish Oil Replacement Strategies for the Production of Aquaculture Feeds
SBC: ABN Topic: N/AIf aquaculture is to become an increasing contributor to the food supply, it is critical that aquaculture feeds become less reliant on marine-derived fishmeal and fish oil as the preferred source of essential proteins and lipids. Not only is the wild fishery from which these products are extracted at maximum sustainable levels of harvest, but also there is increasing concern that these feedstocks ...
SBIR Phase II 2005 Department of Commerce -
Natural and Sustainable Alternatives for Fish Meal/Oil Usage in Atlantic Salmon Feeds
SBC: ABN Topic: 8110The aquaculture industry currently consumes 70 percent of the global production of fish oil and 35 percent of total fishmeal. The salmon and trout fish farming sectors alone consume over one half of the world¿s fish oil. And if fish farming continues to grow at the current rate, then by 2010 the aquaculture industry could well be using all of the world¿s fish oil and half of its fishmeal. The ...
SBIR Phase I 2005 Department of Commerce -
Development of NET-Selective Piperidine-Based PET Ligand
SBC: Acenta Discovery, Inc. Topic: N/ADESCRIPTION (provided by applicant): World-wide public health surveys point to an increasing global health burden resulting from serious brain disorders, particularly mood-related disorders such as depression. The economic burden of depression alone is immense. Of the $83.1 billion spent in 2000 on the treatment of depression and related expenses, $26.1 billion (31 percent) were direct medical cos ...
STTR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health -
Development of a Novel Acoustic Resuscitation Monitor
SBC: Active Signal Technologies, Inc. Topic: N/ADESCRIPTION (provided by applicant): Currently almost half of all trauma mortality is directly or indirectly attributable to hemorrhagic shock, accounting for more than 50,000 deaths yearly in the U.S. and hundreds of billions of dollars in economic costs. Active Signal Technologies proposes to develop an Acoustic Resuscitation Monitor (ARM) for enabling non-invasive assessment of systemic perfusi ...
SBIR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health -
Web-based Training Center
SBC: Advanced Technologies/Laboratories Intl Topic: N/ADESCRIPTION (provided by applicant) The primary aim is to facilitate the development and delivery of live, interactive HAZWOPER training through the use of internet-based Advanced Training Technologies (ATT). To this end, ATL has designed the ATL Web-based Training Center as a fully integrated portal that provides synchronous and asynchronous training from one access point for all students and ...
SBIR Phase II 2005 Department of Health and Human ServicesNational Institutes of Health -
Novel Therapy for Wet Age-Related Macular Degeneration
SBC: ADVANCED VISION THERAPIES, INC. Topic: N/ADESCRIPTION (provided by applicant): Wet age-related macular degeneration (AMD) is the leading cause of blindness in the developed world and represents a disease with a great unmet medical need. The blindness associated with wet AMD is caused by neovascularization and treatments are aimed at inhibiting this progress. The Advanced Vision Therapies, Inc. (AVT) strategy is to combine its gene deliver ...
SBIR Phase II 2005 Department of Health and Human ServicesNational Institutes of Health -
Evaluation of Kininostatin for Treatment of Wet AMD
SBC: ADVANCED VISION THERAPIES, INC. Topic: N/ADESCRIPTION: Advanced Vision Therapies, Inc. (AVT) is developing novel therapies for ocular disorders that are the major causes of blindness in the developed world. The initial indications are the neovascular diseases, wet age-related macular degeneration and diabetic proliferative retinopathy. Disease pathophysiology is characterized by abnormal blood vessel growth in the choroid or retina resul ...
SBIR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health -
RdCVF as a novel therapeutic for retinitis pigmentosa
SBC: ADVANCED VISION THERAPIES, INC. Topic: N/AAdvanced Vision Therapies, Inc. (AVT) is developing novel therapies for ocular disorders that are the major causes of blindness in the developed world. These diseases include the neovascular ocular disorders, wet age-related macular degeneration (AMD) and diabetic proliferative retinopathy, and the retinal degenerative disorders, retinitis pigmentosa (RP), and dry AMD. AVT has developed a novel le ...
SBIR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health -
New Generation of Anthrax Prophylaxis and Therapy
SBC: AFG BIOSOLUTIONS, INC. Topic: N/ADESCRIPTION (provided by applicant): This Phase I SBIR application addresses the NIAID call for high priority biodefense products such as novel vaccines and therapeutics to protect our nation against various biothreat agents. Although these types of proposals do not require a significant amount of preliminary data, we have already performed substantial preliminary experimental work that encourages ...
SBIR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health -
Biofilm development and Eye Infections
SBC: AMULET PHARMACEUTICALS, INC. Topic: N/AContact lens related eye infections impact millions of people yearly. Standard guidelines for lens care can minimize eye infection, but it has been shown that only about 50% of lens wearers adhere to appropriate guidelines. During usual use and storage procedures, microorganisms adhere to contact lenses. Daily lens cleaning removes most of these microorganisms, but sometimes microbes establish bio ...
SBIR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health